Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 CausalMutation disease CLINVAR Structure of the polyisoprenyl-phosphate glycosyltransferase GtrB and insights into the mechanism of catalysis. 26729507 2016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 GeneticVariation disease BEFREE The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy. 23856421 2013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 Biomarker disease GENOMICS_ENGLAND The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy. 23856421 2013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 GeneticVariation disease UNIPROT The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy. 23856421 2013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 Biomarker disease GENOMICS_ENGLAND The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy. 23856421 2013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 CausalMutation disease CLINVAR The present case is the first individual described with DPM1-CDG (CDG-Ie) to also have clinical and muscle biopsy findings consistent with dystroglycanopathy. 23856421 2013
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 GeneticVariation disease BEFREE A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings. 16641202 2006
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 Biomarker disease BEFREE CDG Ie is caused by a deficiency of dolichol-phosphate-mannose synthase 1 (DPM1), an enzyme involved in N-glycan assembly in the endoplasmic reticulum. 15669674 2004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 Biomarker disease GENOMICS_ENGLAND CDG Ie is caused by a deficiency of dolichol-phosphate-mannose synthase 1 (DPM1), an enzyme involved in N-glycan assembly in the endoplasmic reticulum. 15669674 2004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 GeneticVariation disease UNIPROT CDG Ie is caused by a deficiency of dolichol-phosphate-mannose synthase 1 (DPM1), an enzyme involved in N-glycan assembly in the endoplasmic reticulum. 15669674 2004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 GeneticVariation disease UNIPROT Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie) 10642597 2000
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 Biomarker disease GENOMICS_ENGLAND Because DPM1 deficiency, like other subtypes of CDG-I, impairs the assembly of N-glycans, this novel glycosylation defect was named CDG-Ie. 10642602 2000
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 GeneticVariation disease UNIPROT Because DPM1 deficiency, like other subtypes of CDG-I, impairs the assembly of N-glycans, this novel glycosylation defect was named CDG-Ie. 10642602 2000
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie
0.730 Biomarker disease CTD_human